Brief: Paradigm Biopharmaceuticals Announces A$16M Placement
09/12/2024 01:08
Dec 9 (Reuters) - Paradigm Biopharmaceuticals Ltd
PAR.AX :
* A$16M PLACEMENT AT A$0.40 PER SHARE
* PLACEMENT TO FUND GLOBAL PHASE 3 CLINICAL TRIAL SETUP AND
OTHER
STRATEGIC INITIATIVES
Further company coverage: PAR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paradigm Biopharmaceuticals
See all newsBrief: Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration
Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
Australia's Paradigm Biopharmaceuticals slips on discounted placement
Brief: Paradigm Biopharmaceuticals Says Co Completes A$14 Mln Placement
Brief: Paradigm Biopharmaceuticals Requests Trading Halt